During the past decade, Ivirma Madrid conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ivirma Madrid" are "Male Fertility" (1 trials), "Ovarian Reserve" (1 trials), "Sperm" (1 trials), "Sperm DNA Fragmentation" (1 trials) and "Telomeres" (1 trials). Many other conditions were trialed in "Ivirma Madrid" in a lesser frequency.

Most popular intervention types in "Ivirma Madrid" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Danazol/Placebo" (1 trials) and "Without intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ivirma Madrid" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ivirma Madrid". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ivirma Madrid, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ivirma Madrid, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".